Search results
Moderna's New RSV Vaccine Undercuts the Promise of mRNA
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot
Bloomberg· 2 hours agoThe biotech’s lackluster new RSV vaccine undercuts the promise of mRNA to revolutionize health care....
AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect
The Telegraph via Yahoo News· 2 days agoThe Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical...
Metis Global Partners LLC Trims Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 4 hours agoMetis Global Partners LLC reduced its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 19.9% during the fourth quarter, according to the company in its most ...
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation -...
EconoTimes· 5 hours agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU...
Fauci, other top health officials receive Moderna Covid-19 vaccine on camera
AOL· 2 days agoFauci, director of the National Institute of Allergy and Infectious Diseases, received the shot...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 20 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
AstraZeneca pulls its COVID-19 vaccine from the European market
WSB-TV 2 Atlanta· 12 hours agoLONDON — (AP) — The pharma giant AstraZeneca has requested that the European authorization for its...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 22 hours agoAppointments were offered from April and UK Health Security Agency advice on bookings set out the ...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 7 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...